Specifically, we identify the presence of a rare subpopulation of cell cycle-restricted pre-LSCs that have enhanced therapeutic resistance and most importantly represent the population of cells that acquire oncogenic Notch1 mutations necessary for clonal evolution to T-ALL. Here, NOTCH1 is linked to acute lymphoblastic leukemia.